Chlorhexidine Dihydrochloride
Chlorhexidine (dihydrochloride) |
|||
HY-B1145 | MedChemExpress | 100mg | 142.8 EUR |
Chlorhexidine |
|||
C156-1G | TOKU-E | 1 g | 126 EUR |
Chlorhexidine |
|||
C156-5G | TOKU-E | 5 g | 391.2 EUR |
Chlorhexidine |
|||
HY-B1248 | MedChemExpress | 100mg | 142.8 EUR |
Chlorhexidine |
|||
GP9341-1G | Glentham Life Sciences | 1 g | 112.8 EUR |
Chlorhexidine HCl |
|||
abx187869-1kg | Abbexa | 1 kg | 1045.2 EUR |
Chlorhexidine digluconate |
|||
B3525-50 | ApexBio | 50 mg | 153.6 EUR |
Chlorhexidine HCl |
|||
B1695-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
Description: Chlorhexidine hydrochloride is an antiseptic effective against a wide variety of gram-negative and gram-positive organisms. |
|||
Chlorhexidine HCl |
|||
B1695-50 | ApexBio | 50 mg | 153.6 EUR |
Description: Chlorhexidine hydrochloride is an antiseptic effective against a wide variety of gram-negative and gram-positive organisms. |
|||
Chlorhexidine (digluconate) |
|||
HY-B0608 | MedChemExpress | 5g | 267.6 EUR |
Chlorhexidine digluconate |
|||
TBW00044 | ChemNorm | unit | Ask for price |
Chlorhexidine diacetate salt |
|||
C200-25G | TOKU-E | 25 g | 216 EUR |
Chlorhexidine diacetate salt hydrate |
|||
GA1676-100G | Glentham Life Sciences | 100 g | 370.8 EUR |
Chlorhexidine diacetate salt hydrate |
|||
GA1676-1G | Glentham Life Sciences | 1 g | 55.2 EUR |
Chlorhexidine diacetate salt hydrate |
|||
GA1676-25G | Glentham Life Sciences | 25 g | 132 EUR |
Chlorhexidine diacetate salt hydrate |
|||
GA1676-5G | Glentham Life Sciences | 5 g | 84 EUR |
Cefotiam Dihydrochloride |
|||
C095-100MG | TOKU-E | 100 mg | 278.4 EUR |
Cefotiam Dihydrochloride |
|||
C095-50MG | TOKU-E | 50 mg | 172.8 EUR |
Retigabine dihydrochloride |
|||
A3758-10 | ApexBio | 10 mg | 164.4 EUR |
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
|||
Retigabine dihydrochloride |
|||
A3758-100 | ApexBio | 100 mg | 522 EUR |
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
|||
Retigabine dihydrochloride |
|||
A3758-5 | ApexBio | 5 mg | 126 EUR |
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
|||
Retigabine dihydrochloride |
|||
A3758-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 170.4 EUR |
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
|||
Retigabine dihydrochloride |
|||
A3758-50 | ApexBio | 50 mg | 325.2 EUR |
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
|||
Veliparib dihydrochloride |
|||
A3958-10 | ApexBio | 10 mg | 177.6 EUR |
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
|||
Veliparib dihydrochloride |
|||
A3958-200 | ApexBio | 200 mg | 1002 EUR |
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
|||
Veliparib dihydrochloride |
|||
A3958-5 | ApexBio | 5 mg | 150 EUR |
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
|||
Veliparib dihydrochloride |
|||
A3958-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 139.2 EUR |
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
|||
Veliparib dihydrochloride |
|||
A3958-50 | ApexBio | 50 mg | 421.2 EUR |
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
|||
Ethambutol dihydrochloride |
|||
E005-100G | TOKU-E | 100 g | 508.8 EUR |
Ethambutol dihydrochloride |
|||
E005-25G | TOKU-E | 25 g | 171.6 EUR |
Antipain, dihydrochloride |
|||
ADJ692 | Bio Basic | 5mg | 110.53 EUR |
Naftopidil Dihydrochloride |
|||
E1KS1387 | EnoGene | 25mg | 296.4 EUR |
Norquetiapine dihydrochloride |
|||
2362-250 | Biovision | 496.8 EUR | |
Norquetiapine dihydrochloride |
|||
2362-50 | Biovision | 170.4 EUR | |
1400W dihydrochloride |
|||
2055-25 | Biovision | 405.6 EUR | |
1400W dihydrochloride |
|||
2055-5 | Biovision | 151.2 EUR | |
GGACK Dihydrochloride |
|||
1847-5 | Biovision | 5 mg | 382.8 EUR |
Description: A potent and irreversible inhibitor of Urokinase (uPA (IC??<1 µM), Factor VIIa, Factor IXa, Factor Xa, and trypsin. |
|||
PPACK Dihydrochloride |
|||
1848-5 | Biovision | 301.2 EUR | |
Puromycin Dihydrochloride |
|||
1860-100 | Biovision | 326.4 EUR | |
Puromycin Dihydrochloride |
|||
1860-1000 | Biovision | 1554 EUR | |
Puromycin Dihydrochloride |
|||
1860-25 | Biovision | 151.2 EUR | |
Puromycin Dihydrochloride |
|||
1860-250 | Biovision | 548.4 EUR | |
Puromycin Dihydrochloride |
|||
1860-500 | Biovision | 966 EUR | |
Emetine dihydrochloride |
|||
1970-250 | Biovision | 430.8 EUR | |
Emetine dihydrochloride |
|||
1970-50 | Biovision | 164.4 EUR | |
Berbamine dihydrochloride |
|||
2520-100 | Biovision | 157.2 EUR | |
Berbamine dihydrochloride |
|||
2520-500 | Biovision | 444 EUR | |
Vatalanib Dihydrochloride |
|||
2025-25 | Biovision | 366 EUR | |
Vatalanib Dihydrochloride |
|||
2025-5 | Biovision | 151.2 EUR | |
Antipain dihydrochloride |
|||
2834-25 | Biovision | 392.4 EUR | |
Antipain dihydrochloride |
|||
2834-5 | Biovision | 144 EUR | |
Dorsmorphin dihydrochloride |
|||
2835-25 | Biovision | 705.6 EUR | |
Dorsmorphin dihydrochloride |
|||
2835-5 | Biovision | 222 EUR | |
AT7867 dihydrochloride |
|||
A3199-10 | ApexBio | 10 mg | 408 EUR |
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics. |
|||
AT7867 dihydrochloride |
|||
A3199-100 | ApexBio | 100 mg | 2210.4 EUR |
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics. |
|||
AT7867 dihydrochloride |
|||
A3199-5 | ApexBio | 5 mg | 320.4 EUR |
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics. |
|||
AT7867 dihydrochloride |
|||
A3199-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 344.4 EUR |
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics. |
|||
AT7867 dihydrochloride |
|||
A3199-50 | ApexBio | 50 mg | 1537.2 EUR |
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics. |
|||
Canertinib dihydrochloride |
|||
A3276-10 | ApexBio | 10 mg | 129.6 EUR |
Description: Canertinib dihydrochloride is a selective inhibitor of Pan-erbB tyrosine kinase with IC50 value of 3.5 nM [1].ErbB receptor family is a member of the receptor tyrosine kinase superfamily and plays an important role in the normal breast development. |
|||
Canertinib dihydrochloride |
|||
A3276-100 | ApexBio | 100 mg | 226.8 EUR |
Description: Canertinib dihydrochloride is a selective inhibitor of Pan-erbB tyrosine kinase with IC50 value of 3.5 nM [1].ErbB receptor family is a member of the receptor tyrosine kinase superfamily and plays an important role in the normal breast development. |
|||
Canertinib dihydrochloride |
|||
A3276-50 | ApexBio | 50 mg | 177.6 EUR |
Description: Canertinib dihydrochloride is a selective inhibitor of Pan-erbB tyrosine kinase with IC50 value of 3.5 nM [1].ErbB receptor family is a member of the receptor tyrosine kinase superfamily and plays an important role in the normal breast development. |
|||
Inolitazone dihydrochloride |
|||
A3499-5 | ApexBio | 5 mg | 837.6 EUR |
Description: Description:IC50 Value: 0.8 nM [1]Inolitazone(RS5444) is a novel high-affinity PPARgamma agonist, which activates PPARgamma with an EC50 about 1/50th that of rosiglitazone and has no effect on RIE cells that do not express PPARgamma. |
|||
DMPQ Dihydrochloride |
|||
20-abx076714 | Abbexa |
|
|
H89 Dihydrochloride |
|||
20-abx076747 | Abbexa |
|
|
Vatalanib Dihydrochloride |
|||
20-abx076544 | Abbexa |
|
|
Alexidine dihydrochloride |
|||
A4542-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
Description: Selective inhibitor of protein tyrosine phosphatases localized to mitochondrion 1 (PTPMT1) (IC50 = 1.08 ?M in vitro). Stimulates increased insulin secretion by ?-cells in rat pancreatic islets. Displays antitcancer properties in FaDu cells. |
|||
Alexidine dihydrochloride |
|||
A4542-50 | ApexBio | 50 mg | 220.8 EUR |
Description: Selective inhibitor of protein tyrosine phosphatases localized to mitochondrion 1 (PTPMT1) (IC50 = 1.08 ?M in vitro). Stimulates increased insulin secretion by ?-cells in rat pancreatic islets. Displays antitcancer properties in FaDu cells. |
|||
GGACK Dihydrochloride |
|||
A2582-5 | ApexBio | 5 mg | 282 EUR |
Description: A potent and irreversible inhibitor of Urokinase (uPA (IC??<1 µM), Factor VIIa, Factor IXa, Factor Xa, and trypsin. |
|||
PPACK Dihydrochloride |
|||
A2588-10 | ApexBio | 10 mg | 423.6 EUR |
Description: PPACK Dihydrochloride is the dihydrochloride form of its active component PPACK (D-Phenylalanyl-L-prolyl-L-arginine chloromethyl ketone), a potent, selective and irreversible inhibitor of thrombin that inhibits human ?-thrombin with inhibition constant Kivalue of 0.24 nM. |
|||
PPACK Dihydrochloride |
|||
A2588-25 | ApexBio | 25 mg | 908.4 EUR |
Description: PPACK Dihydrochloride is the dihydrochloride form of its active component PPACK (D-Phenylalanyl-L-prolyl-L-arginine chloromethyl ketone), a potent, selective and irreversible inhibitor of thrombin that inhibits human ?-thrombin with inhibition constant Kivalue of 0.24 nM. |